HOME > TOP STORIES
TOP STORIES
-
ORGANIZATION EFPIA Japan Chief Eyes New Funding Model for Innovative but Pricey Therapies
October 26, 2018
-
BUSINESS Tecentriq, Hemlibra Get Off with a Bang, Clear 2018 Targets Already: Chugai
October 25, 2018
-
BUSINESS AVXS-101 Is Game Changer for SMA Treatment: Novartis Neuroscience Chief
October 24, 2018
-
BUSINESS Parexel CEO Sees Bright Future for Japan CRO Market
October 23, 2018
-
BUSINESS Mundipharma Shooting for Japan Sales of US$500 Million in 10 Years: CEO
October 22, 2018
-
BUSINESS Prescribers Asked to Stop New Enbrel Biosimilar Use as Maker Can’t Keep Up with Demand
October 19, 2018
-
REGULATORY 3 Pharma Groups Warn against Drug Price Cut in April 2019: Chuikyo
October 18, 2018
-
BUSINESS JAK Inhibitor Battle for Atopic Dermatitis Intensifying, 1st Japan Filing Might Be Near
October 17, 2018
-
REGULATORY As Abe Vows to Deliver on Tax Hike Plan, 3 Pharma Groups to Push for October 2019 Price Revision
October 16, 2018
-
REGULATORY MEXT Kicks Off “Open Innovation Organization” Initiative, 3 Universities to Push Drug Discovery
October 15, 2018
-
BUSINESS Chugai Sues Daiichi Sankyo, Pfizer over Herceptin Biosimilars
October 15, 2018
-
TRENDS Hep C Market Shrinking towards Disease Elimination in 2030
October 12, 2018
-
BUSINESS Nippon Shinyaku to Expand Contract Manufacturing Biz with New Facility to Start Full Operation in Feb.
October 12, 2018
-
REGULATORY MHLW Panelists Frown on Use of Economic Evaluations for Reimbursement Decisions
October 11, 2018
-
REGULATORY MOF Reiterates Drug Cost Optimization, but Makes No Fresh Proposal: Fiscal System Council
October 10, 2018
-
BUSINESS Funding Disclosures Reveal Changes in Money Flows; Biz Models, Pricing Reform Driving the Shift
October 9, 2018
-
BUSINESS Amgen to Remain Active Investor in Japan as It Eyes 2020 Launch of Stand-Alone Subsidiary
October 4, 2018
-
BUSINESS Bavencio on Back Foot, but Merck KGaA Has High Hopes for Next-Gen I/O Therapy M7824
October 3, 2018
-
ACADEMIA I/O Pioneers Win Nobel Prize in Medicine; Honjo Prods Japan Firms to Make More Academic Investment at Home
October 2, 2018
-
BUSINESS Wholesalers See “Some Reduction in Yakkasa” in Price Negotiations under New Guidelines: Will Reduction Continue?
October 2, 2018
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
